These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9860239)

  • 1. Eosinophil leukocyte degranulation in response to serum-opsonized beads: C5a and platelet-activating factor enhance ECP release, with roles for protein kinases A and C.
    Egesten A; Malm J
    Allergy; 1998 Nov; 53(11):1066-73. PubMed ID: 9860239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophil granulocyte interaction with serum-opsonized particles: binding and degranulation are enhanced by tumor necrosis factor alpha.
    Egesten A; Blom M; Calafat J; Janssen H; Knol EF
    Int Arch Allergy Immunol; 1998 Feb; 115(2):121-8. PubMed ID: 9482700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of human eosinophil activation by complement protein C5a and platelet-activating factor: similar functional responses are accompanied by different morphologic alterations.
    Zeck-Kapp G; Kroegel C; Riede UN; Kapp A
    Allergy; 1995 Jan; 50(1):34-47. PubMed ID: 7741187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degranulation from human eosinophils stimulated with C3a and C5a.
    Takafuji S; Tadokoro K; Ito K; Dahinden CA
    Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):27-9. PubMed ID: 8156000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phorbol ester-induced degranulation in adherent human eosinophil granulocytes is dependent on CD11/CD18 leukocyte integrins.
    Egesten A; Gullberg U; Olsson I; Richter J
    J Leukoc Biol; 1993 Mar; 53(3):287-93. PubMed ID: 8095965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel thromboxane synthetase inhibitor, DP-1904, inhibits human blood eosinophil degranulation.
    Agrawal DK; Takami M; Ono S
    Inflammation; 1997 Feb; 21(1):1-8. PubMed ID: 9179617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the release of eosinophil cationic protein by eosinophil adhesion.
    Xu X; Håkansson L
    Clin Exp Allergy; 2000 Jun; 30(6):794-806. PubMed ID: 10848898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of interleukin (IL)-3 and IL-5 on human eosinophil degranulation induced by complement components C3a and C5a.
    Takafuji S; Tadokoro K; Ito K
    Allergy; 1996 Aug; 51(8):563-8. PubMed ID: 8874660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophils maintain their capacity to signal and release eosinophil cationic protein upon repetitive stimulation with the same agonist.
    Simon HU; Weber M; Becker E; Zilberman Y; Blaser K; Levi-Schaffer F
    J Immunol; 2000 Oct; 165(7):4069-75. PubMed ID: 11034418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of PAF, FMLP and opsonized zymosan on the release of ECP, elastase and superoxide from human granulocytes.
    Turner NC; Wood LJ; Foster M; Gueremy T
    Eur Respir J; 1994 May; 7(5):934-40. PubMed ID: 8050551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of protein kinases A and C demonstrates dual modes of response in human eosinophils stimulated with platelet-activating factor.
    Takizawa T; Kato M; Kimura H; Suzuki M; Tachibana A; Obinata H; Izumi T; Tokuyama K; Morikawa A
    J Allergy Clin Immunol; 2002 Aug; 110(2):241-8. PubMed ID: 12170264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of granule proteins from human eosinophils stimulated with mast-cell mediators.
    Takafuji S; Tadokoro K; Ito K; Nakagawa T
    Allergy; 1998 Oct; 53(10):951-6. PubMed ID: 9821474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation.
    Carlson M; Peterson C; Venge P
    Allergy; 1993 Aug; 48(6):437-42. PubMed ID: 8238799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil degranulation in the presence of lung fibroblasts.
    Takafuji S; Shoji S; Ito K; Yamamoto K; Nakagawa T
    Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():52-4. PubMed ID: 9758898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of human lung fibroblasts on eosinophil degranulation.
    Takafuji S; Miyakuni Y; Nakagawa T; Shoji S; Murata S; Yamamoto K; Ito K
    Allergy; 2000 Dec; 55(12):1170-8. PubMed ID: 11117275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of physiologic soluble agonists on leukotriene C4 production and degranulation by human eosinophils.
    Takafuji S; Tadokoro K; Ito K; Dahinden CA
    Int Arch Allergy Immunol; 1995; 108 Suppl 1():36-8. PubMed ID: 7549519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential inhibition of inflammatory effector functions by petasin, isopetasin and neopetasin in human eosinophils.
    Thomet OA; Wiesmann UN; Blaser K; Simon HU
    Clin Exp Allergy; 2001 Aug; 31(8):1310-20. PubMed ID: 11529903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of formoterol on platelet-activating factor induced eosinophil chemotaxis and degranulation.
    Eda R; Sugiyama H; Hopp RJ; Okada C; Bewtra AK; Townley RG
    Int Arch Allergy Immunol; 1993; 102(4):391-8. PubMed ID: 8241801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis toxin shows distinct early signalling events in platelet-activating factor-, leukotriene B4-, and C5a-induced eosinophil homotypic aggregation in vitro and recruitment in vivo.
    Teixeira MM; Giembycz MA; Lindsay MA; Hellewell PG
    Blood; 1997 Jun; 89(12):4566-73. PubMed ID: 9192781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions.
    Hatzelmann A; Tenor H; Schudt C
    Br J Pharmacol; 1995 Feb; 114(4):821-31. PubMed ID: 7539697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.